// PREVENTIVE-MEDICINE Questions
// Auto-generated from questions.ts
// Total Questions: 15

import { Question } from '../types';

export const questions: Question[] = [
{
    id: "neet-pg-2023-116",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "e In a village, it is observed that several farmers have crossed gait and use a stick for support to stand up and walk. Due to poor yield from farms, they consume meals containing rice and r pulses only. Supplementing their diet with which of the following vitamins could have pPrevented this?",
    options: [
      "V itamin A",
      "Vitamin D",
      "Vitamin C",
      "Vitamin B",
    ],
    correctAnswer: 2,
    explanation: "‚úÖ ANSWER: **Vitamin B (Option D) - Likely B1/B6/B12**\n\nüî¨ **PERIPHERAL NEUROPATHY IN FARMERS:**\n\n**CLINICAL (THIS CASE):**\n‚Ä¢ **Crossed gait** (ataxia) ‚≠ê\n‚Ä¢ **Need stick for support** (weakness)\n‚Ä¢ **Diet:** Rice + pulses ONLY ‚≠ê (poor, monotonous)\n\n**LIKELY DIAGNOSIS:** **Peripheral neuropathy** from **B vitamin deficiency** ‚≠ê‚≠ê‚≠ê\n\n**VITAMIN B DEFICIENCIES:**\n\n**1. Vitamin B1 (Thiamine):** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Dry beriberi** (peripheral neuropathy)\n‚Ä¢ **Rice-based diet** (polished rice lacks thiamine)\n‚Ä¢ **Weakness**, **ataxia**\n\n**2. Vitamin B12:**\n‚Ä¢ **Subacute combined degeneration**\n‚Ä¢ **Ataxia** (dorsal column)\n\n**3. Vitamin B6:**\n‚Ä¢ **Peripheral neuropathy**\n\n**WHY NOT VITAMIN C:**\n‚Ä¢ **Scurvy:** Bleeding, gum disease (NOT neuropathy)\n\nüí° **KEY:** **Ataxia + Weakness + Rice diet = B vitamin deficiency (esp. B1)** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-117",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "Research is being conducted to find the association between aniline dye exposure and bladder cancer in workers who have worked in the industry for >20 years. Two groups were formed: one directly involved with dye handling and the other group consisting of office clerks not directly exposed to the dye. Years of occupation were noted from records. What type of study is being performed?",
    options: [
      "Retrospective cohort study",
      "Prospective cohort study",
      "Case-control study",
      "Intervention and respons d",
    ],
    correctAnswer: 0,
    explanation: "‚úÖ ANSWER: **Retrospective cohort study (Option A)**\n\nüî¨ **STUDY DESIGN:**\n\n**KEY FEATURES (THIS STUDY):**\n\n**1. TWO GROUPS** based on **EXPOSURE** ‚≠ê‚≠ê‚≠ê:\n‚Ä¢ **Exposed:** Dye handlers\n‚Ä¢ **Unexposed:** Office clerks\n\n**2. FOLLOWED OVER TIME** for outcome (bladder cancer)\n\n**3. RETROSPECTIVE** ‚≠ê‚≠ê‚≠ê:\n‚Ä¢ **Data from PAST records** (\"years of occupation from records\")\n‚Ä¢ **Exposure already occurred**\n‚Ä¢ **Looking back** at exposure ‚Üí outcome\n\n**COHORT STUDY CHARACTERISTICS:**\n‚Ä¢ **Start with exposure status** ‚≠ê\n‚Ä¢ **Follow for outcome**\n‚Ä¢ **Calculate:** Relative risk, incidence\n\n**VS CASE-CONTROL:**\n‚Ä¢ **Case-control:** Start with OUTCOME (cases/controls) ‚Üí look back for exposure\n\n**VS PROSPECTIVE COHORT:**\n‚Ä¢ **Prospective:** Exposure identified NOW ‚Üí follow forward\n\nüí° **KEY:** **Exposure groups + Past records ‚Üí Retrospective cohort** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-120",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "The blood pressure of a population was tracked from childhood to adulthood. It was observed d that those who had lower BP in childhood had low BP in adulthood, while those who had higher BP in childhood had high BP in adulthood. This can be best described as",
    options: [
      "Rule of halves",
      "Tracking of blood pressure a",
      "STEPwise approach",
      "Primordial approach",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Tracking of blood pressure (Option B)**\n\nüî¨ **TRACKING PHENOMENON:**\n\n**DEFINITION:** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Maintenance of relative rank** over time\n‚Ä¢ **Childhood BP status PREDICTS adult BP status** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **High in childhood ‚Üí High in adulthood**\n‚Ä¢ **Low in childhood ‚Üí Low in adulthood**\n\n**THIS CASE:** Perfect example of tracking ‚≠ê\n\n**SIGNIFICANCE:**\n‚Ä¢ **Identifies high-risk children** early\n‚Ä¢ **Early intervention** can prevent adult hypertension\n‚Ä¢ **Prevention starts in childhood**\n\n**OTHER CONCEPTS:**\n\n**Rule of halves (HTN):**\n‚Ä¢ 1/2 know they have HTN\n‚Ä¢ 1/2 of those on treatment\n‚Ä¢ 1/2 of those controlled\n\n**STEPwise approach:**\n‚Ä¢ WHO surveillance method\n\n**Primordial prevention:**\n‚Ä¢ Prevent risk factors from developing\n\nüí° **KEY:** **Childhood BP predicts adult BP = Tracking** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    imageUrl: "/images/questions/2023/page59_img35.jpeg",
    year: 2023
  },{
    id: "neet-pg-2023-122",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "A 30-week primigravida complaints of reduced vision at night. She has been avoiding papaya, mango, and other fruits throughout her pregnancy as she thinks they could be abortifacients. It is the primary duty of which of the following workers to provide counseling and information to the patient?",
    options: [
      "ANM",
      "AWW",
      "Trained birth attendant",
      "ASHA d",
    ],
    correctAnswer: 3,
    explanation: "‚úÖ ANSWER: **ASHA (Accredited Social Health Activist) (Option D)**\n\nüî¨ **NIGHT BLINDNESS IN PREGNANCY:**\n\n**THIS CASE:**\n‚Ä¢ **30-week pregnant** (3rd trimester)\n‚Ä¢ **Night blindness** ‚≠ê‚≠ê‚≠ê (Vitamin A deficiency)\n‚Ä¢ **Avoiding fruits** (papaya, mango - rich in Vitamin A)\n\n**HEALTH WORKERS & ROLES:**\n\n**ASHA (Accredited Social Health Activist):** ‚≠ê‚≠ê‚≠ê **(ANSWER)**\n‚Ä¢ **PRIMARY contact** between community and health system\n‚Ä¢ **Health education & counseling** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Antenatal home visits**\n‚Ä¢ **Dispels myths/misconceptions**\n‚Ä¢ **Promotes institutional delivery**\n\n**ANM (Auxiliary Nurse Midwife):**\n‚Ä¢ **Sub-center level**\n‚Ä¢ **Clinical care**, immunization\n\n**AWW (Anganwadi Worker):**\n‚Ä¢ **Nutrition** supplementation (ICDS)\n‚Ä¢ **Pre-school education**\n\n**TBA (Trained Birth Attendant):**\n‚Ä¢ **Assists in deliveries**\n\nüí° **KEY:** **ASHA = Primary health educator & counselor at community level** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-124",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "A 22-year-old female comes to the STI clinic with minimal vaginal dischargre. On speculum examination, erosions are seen on the cervix. Which of the following kit should be given to this patient? e",
    options: [
      "Green d",
      "Red",
      "Grey",
      "Yellow a",
    ],
    correctAnswer: 2,
    explanation: "‚úÖ ANSWER: **Grey kit (Option C)**\n\nüî¨ **STI SYNDROMIC MANAGEMENT - COLOR-CODED KITS:**\n\n**THIS CASE:**\n‚Ä¢ **Minimal vaginal discharge**\n‚Ä¢ **Cervical erosions** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ = **CERVICITIS** syndrome\n\n**GREY KIT** ‚≠ê‚≠ê‚≠ê **(ANSWER)**\n‚Ä¢ **For:** Cervicitis\n‚Ä¢ **Contains:**\n  - **Azithromycin 1g** (single dose) - for Chlamydia ‚≠ê\n  - **Cefixime 400mg** (single dose) - for Gonorrhea ‚≠ê\n\n**OTHER KITS:**\n\n**RED KIT:** Genital ulcer disease\n‚Ä¢ Azithromycin + Benzathine penicillin\n\n**YELLOW KIT:** Urethral discharge\n‚Ä¢ Azithromycin + Cefixime\n\n**GREEN KIT:** Vaginal discharge\n‚Ä¢ Fluconazole + Metronidazole + Azithromycin\n\n**BLUE KIT:** Lower abdominal pain (PID)\n‚Ä¢ Doxycycline + Metronidazole + Cefixime\n\nüí° **KEY:** **Cervical erosions/Cervicitis = Grey kit (Azithromycin + Cefixime)** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-125",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "The years of potential life lost could be attributed to, e",
    options: [
      "Years lost to morbidity",
      "Years lost due to premature death OP3: Years lost to disability O 4: Years lost to poor quality of life",
      "Option 3",
      "Option 4",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Years lost due to premature death (Option B)**\n\nüî¨ **YEARS OF POTENTIAL LIFE LOST (YPLL):**\n\n**DEFINITION:** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Years lost due to PREMATURE death** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ Death **before expected age** (e.g., before 65 or 75 years)\n‚Ä¢ **Mortality indicator**\n\n**CALCULATION:**\n‚Ä¢ YPLL = (Expected age) - (Age at death)\n‚Ä¢ **Example:** Death at 40, expected 75 ‚Üí YPLL = 35 years\n\n**SIGNIFICANCE:**\n‚Ä¢ **Emphasizes deaths at younger ages** ‚≠ê\n‚Ä¢ **Different from crude mortality rate**\n‚Ä¢ **Accidents/injuries** rank higher with YPLL\n\n**OTHER CONCEPTS:**\n\n**DALY (Disability-Adjusted Life Years):**\n‚Ä¢ **YLL** (Years of Life Lost) + **YLD** (Years Lost to Disability)\n‚Ä¢ **Combines mortality & morbidity** ‚≠ê\n\n**QALY (Quality-Adjusted Life Years):**\n‚Ä¢ **Accounts for quality of life**\n\nüí° **KEY:** **YPLL = Years lost due to PREMATURE death** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-127",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "r In a 10-year-old school child, which of the following vaccines is given as a part of the school imPmunization program?",
    options: [
      "M easles vaccine",
      "Rotavirus vaccine",
      "TT/Td vaccine",
      "Hepatitis B vaccine",
    ],
    correctAnswer: 2,
    explanation: "‚úÖ ANSWER: **TT/Td vaccine (Tetanus Toxoid/Tetanus-diphtheria) (Option C)**\n\nüî¨ **SCHOOL IMMUNIZATION PROGRAM:**\n\n**AGE 10 YEARS:** **TT/Td vaccine** ‚≠ê‚≠ê‚≠ê **(ANSWER)**\n‚Ä¢ **Tetanus toxoid** booster\n‚Ä¢ Or **Td** (Tetanus + reduced diphtheria)\n\n**NATIONAL IMMUNIZATION SCHEDULE:**\n\n**SCHOOL ENTRY (5-6 years):**\n‚Ä¢ **DPT booster** (1st booster)\n‚Ä¢ **OPV booster**\n\n**10 YEARS:**\n‚Ä¢ **TT/Td** ‚≠ê‚≠ê‚≠ê\n\n**16 YEARS:**\n‚Ä¢ **Td** (2nd booster)\n\n**WHY NOT OTHERS:**\n‚Ä¢ **Measles:** Given at 9-12 months (NOT at 10 years)\n‚Ä¢ **Rotavirus:** Given in infancy (<6 months)\n‚Ä¢ **Hepatitis B:** Birth, 6 weeks, 6 months (NOT at 10 years)\n\n**TT SCHEDULE:**\n‚Ä¢ **Total 5 doses** for lifetime protection\n‚Ä¢ **Pregnant women:** 2 doses (Td1, Td2)\n\nüí° **KEY:** **10-year school immunization = TT/Td vaccine** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-129",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "Which of the following statements is true about cancer treatment according to the Colombo plan? L",
    options: [
      "Help with PET scan units for diagnosis of cance p",
      "Human resource strengthening",
      "Setting up chemotherapy units",
      "Setting up cobalt therapy units r",
    ],
    correctAnswer: 3,
    explanation: "‚úÖ ANSWER: **Setting up cobalt therapy units (Option D)**\n\nüî¨ **COLOMBO PLAN (Cancer Control):**\n\n**FOCUS:** **Radiotherapy infrastructure** ‚≠ê‚≠ê‚≠ê\n\n**MAIN COMPONENT:**\n‚Ä¢ **Cobalt-60 therapy units** ‚≠ê‚≠ê‚≠ê **(ANSWER)**\n‚Ä¢ **Teletherapy** (external beam radiotherapy)\n‚Ä¢ **Cancer treatment** in developing countries\n\n**BACKGROUND:**\n‚Ä¢ **1995** - Indian initiative\n‚Ä¢ **Assist neighboring countries**\n‚Ä¢ **Sri Lanka, Bangladesh, Myanmar, etc.**\n‚Ä¢ **Provide radiotherapy** facilities\n\n**COBALT-60 UNITS:**\n‚Ä¢ **Gamma radiation** source\n‚Ä¢ **Cancer treatment** (teletherapy)\n‚Ä¢ **Cost-effective** alternative to linear accelerators\n‚Ä¢ **Simpler maintenance**\n\n**CONTRAST:**\n‚Ä¢ **NOT** for PET scans (diagnostic)\n‚Ä¢ **NOT** chemotherapy-focused\n‚Ä¢ **Primary focus:** RADIOTHERAPY ‚≠ê\n\nüí° **KEY:** **Colombo Plan = Setting up Cobalt-60 radiotherapy units** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-130",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "A poor farmer with a history of successive crop failure develops progressive spastic paraparesis, signs of upper motor neuron paralysis, and gait instability. Name the toxin responsible for this condition.",
    options: [
      "Aflatoxin",
      "Beta-oxalyl-amino-alanine",
      "Ergot alkaloids",
      "Fusarium toxin",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Beta-oxalyl-amino-alanine (BOAA) (Option B)**\n\nüî¨ **LATHYRISM:**\n\n**TOXIN:** **Beta-N-oxalyl-amino-L-alanine (BOAA)** ‚≠ê‚≠ê‚≠ê\n\n**SOURCE:** **Lathyrus sativus** (Grass pea/Khesari dal) ‚≠ê‚≠ê‚≠ê\n\n**CLINICAL (THIS CASE):**\n‚Ä¢ **Progressive spastic paraparesis** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **UMN signs** (hyperreflexia, extensor plantars) ‚≠ê\n‚Ä¢ **Gait instability** (scissoring gait)\n‚Ä¢ **Lower limb weakness**\n‚Ä¢ **IRREVERSIBLE** neurological damage\n\n**CONTEXT:**\n‚Ä¢ **Poor farmers** ‚≠ê\n‚Ä¢ **Crop failure** ‚Üí Reliance on cheap Khesari dal\n‚Ä¢ **Prolonged consumption** (>3 months)\n\n**MECHANISM:**\n‚Ä¢ **Excitotoxic** to motor neurons\n‚Ä¢ **Upper motor neuron** damage (corticospinal tract)\n\n**OTHER TOXINS:**\n‚Ä¢ **Aflatoxin:** Hepatotoxic (liver cancer)\n‚Ä¢ **Ergot:** Gangrene, convulsions\n‚Ä¢ **Fusarium:** Alimentary toxic aleukia\n\nüí° **KEY:** **Lathyrism = BOAA from Khesari dal ‚Üí Spastic paraparesis** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-131",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "e A young male came to the hospital with a clean-cut wound without any bleeding. The patient received a full course of tetanus vaccination 10 years ago. What is the best management for this patient? d",
    options: [
      "Human tetanus immunoglobulin and full course of vaccine",
      "Human tetanus immunoglobulin only",
      "Single-dose tetanus toxoid a",
      "Full course tetanus toxoid",
    ],
    correctAnswer: 2,
    explanation: "‚úÖ ANSWER: **Single-dose tetanus toxoid (Option C)**\n\nüî¨ **TETANUS PROPHYLAXIS IN WOUNDS:**\n\n**THIS CASE:**\n‚Ä¢ **Clean wound** ‚≠ê (low risk)\n‚Ä¢ **Full vaccination 10 years ago** ‚≠ê‚≠ê‚≠ê\n\n**MANAGEMENT:** **Single TT booster** ‚≠ê‚≠ê‚≠ê **(ANSWER)**\n\n**TETANUS PROPHYLAXIS GUIDE:**\n\n**CLEAN, MINOR WOUNDS:**\n‚Ä¢ **<3 primary doses:** Complete series\n‚Ä¢ **‚â•3 doses, last >10 years:** **TT booster** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **‚â•3 doses, last <10 years:** Nothing\n‚Ä¢ **NO need for TIG**\n\n**DIRTY/TETANUS-PRONE WOUNDS:**\n‚Ä¢ **<3 doses:** TT + **TIG** ‚≠ê\n‚Ä¢ **‚â•3 doses, last >5 years:** TT booster\n‚Ä¢ **‚â•3 doses, last <5 years:** Nothing\n\n**TETANUS-PRONE WOUNDS:**\n‚Ä¢ **>6 hours old**\n‚Ä¢ **>1 cm deep**\n‚Ä¢ **Contaminated** (soil, feces)\n‚Ä¢ **Devitalized tissue**\n\nüí° **KEY:** **Clean wound + Vaccinated >10 yrs ago = Single TT booster** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-132",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "e How is water collected for bacteriological examination during a disease outbreak?",
    options: [
      "Collect water from already leaking taps OP2: Before collecting, let water flow for at least 1 minut O 3: Water sample container is kept close to the tap avoid spillag O4: Collect from a gentle stream of water to avoid splashing",
      "Option 2",
      "Option 3",
      "Collect from a gentle stream of water to avoid splashing",
    ],
    correctAnswer: 3,
    explanation: "‚úÖ ANSWER: **Collect from a gentle stream of water to avoid splashing (Option D)**\n\nüî¨ **BACTERIOLOGICAL WATER SAMPLING:**\n\n**CORRECT TECHNIQUE:**\n\n**1. Collect from gentle stream** ‚≠ê‚≠ê‚≠ê **(ANSWER)**\n‚Ä¢ **Avoid splashing** (prevents contamination)\n‚Ä¢ **Avoid air bubbles**\n\n**2. Let water flow 2-3 minutes FIRST** ‚≠ê\n‚Ä¢ **NOT \"at least 1 minute\"** (too short)\n‚Ä¢ **Flush stagnant water**\n‚Ä¢ **Get representative sample**\n\n**3. Use sterile bottle** ‚≠ê\n‚Ä¢ **Sodium thiosulfate** (if chlorinated)\n‚Ä¢ **Leave air space** (for mixing)\n\n**4. Transport:**\n‚Ä¢ **<6 hours** (or refrigerate)\n‚Ä¢ **Ice pack** (4¬∞C)\n\n**WRONG:**\n‚Ä¢ ‚ùå **Leaking taps** (contaminated)\n‚Ä¢ ‚ùå **Only 1 minute** flow (insufficient)\n‚Ä¢ ‚ùå **Bottle close to tap** (splash contamination)\n\n**SAMPLING SITES:**\n‚Ä¢ **Distribution system**\n‚Ä¢ **Source** (well, tank)\n‚Ä¢ **Consumer tap**\n\nüí° **KEY:** **Gentle stream to avoid splashing (prevents false contamination)** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-133",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "A boys' hostel has an outbreak of fever cases with headache, followed by the development of pleomorphic rashes sparing palms and soles. What is the next best step in the management of suspected cases? VZIG-Varicella zoster immunoglobulin",
    options: [
      "Isolate for 6 days after giving acyclovir, followed by VZIG within 72 hours of exposure.",
      "Isolate for 12 days after giving acyclovir, followed by VZIG within 48 hours of exposure",
      "Isolate for 6 days r",
      "Only give VZIG",
    ],
    correctAnswer: 2,
    explanation: "‚úÖ ANSWER: **Isolate for 6 days (Option C)**\n\nüî¨ **CHICKENPOX OUTBREAK MANAGEMENT:**\n\n**THIS CASE:**\n‚Ä¢ **Fever + headache**\n‚Ä¢ **Pleomorphic rash** ‚≠ê‚≠ê‚≠ê (macules, papules, vesicles, crusts together)\n‚Ä¢ **Spares palms & soles** ‚≠ê\n‚Ä¢ = **CHICKENPOX (Varicella)**\n\n**ISOLATION:**\n‚Ä¢ **Isolate for 6 days** ‚≠ê‚≠ê‚≠ê **(ANSWER)**\n‚Ä¢ **Until all lesions crust over** (usually 5-7 days)\n‚Ä¢ **Highly contagious** (airborne + contact)\n\n**VZIG (Varicella-Zoster Immunoglobulin):**\n‚Ä¢ **For HIGH-RISK exposed contacts** only ‚≠ê\n‚Ä¢ **NOT for index cases** (already infected)\n‚Ä¢ **Within 96 hours** of exposure\n‚Ä¢ **High-risk:** Immunocompromised, pregnant, neonates\n\n**ACYCLOVIR:**\n‚Ä¢ **Consider for:** Adults, immunocompromised, severe cases\n‚Ä¢ **NOT routine** for healthy children\n\n**OUTBREAK CONTROL:**\n‚Ä¢ **Isolate cases** ‚≠ê\n‚Ä¢ **Identify contacts**\n‚Ä¢ **Vaccinate susceptible contacts**\n\nüí° **KEY:** **Chickenpox cases ‚Üí Isolate for 6 days (until crusting)** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-189",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "A 35-year-old homeless man presented with a 1-month history of fever, cough, and weight loss. Both sputum smears turned out to be negative, but the chest x-ray ordered was suggestive of tuberculosis. According to the recent NTEP guidelines, which is the next best line of management?",
    options: [
      "Repeat sputum smears",
      "Ask for CBNAAT",
      "Ask for line probe assay",
      "Wait until TB culture results to start ATT r",
    ],
    correctAnswer: 1,
    explanation: "‚úÖ ANSWER: **Ask for CBNAAT (Option B)**\n\nüî¨ **NTEP (National TB Elimination Program) GUIDELINES:**\n\n**THIS CASE:**\n‚Ä¢ **Homeless man** ‚≠ê (high-risk)\n‚Ä¢ **Fever, cough, weight loss** (TB symptoms) ‚≠ê\n‚Ä¢ **2 sputum smears NEGATIVE** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **CXR suggestive of TB** ‚≠ê\n\n**NEXT STEP:** **CBNAAT (GeneXpert)** ‚≠ê‚≠ê‚≠ê **(ANSWER)**\n\n**NTEP ALGORITHM:**\n\n**1. Sputum smear (2 samples)**\n‚Ä¢ **If POSITIVE:** Start ATT\n‚Ä¢ **If NEGATIVE:** ‚Üì\n\n**2. CBNAAT** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Next test** if smear negative\n‚Ä¢ **Detects MTB** + **Rifampicin resistance**\n‚Ä¢ **Rapid** (2 hours)\n‚Ä¢ **High sensitivity** (>95%)\n\n**3. If CBNAAT negative but CXR suggestive:**\n‚Ä¢ **Trial of antibiotics** (non-TB)\n‚Ä¢ **Repeat CBNAAT** if no improvement\n‚Ä¢ **Consider empirical ATT**\n\n**WHY NOT OTHERS:**\n‚Ä¢ **Repeat smear:** LOW yield if already negative\n‚Ä¢ **LPA:** For drug resistance testing (AFTER diagnosis)\n‚Ä¢ **Wait for culture:** Takes 6-8 weeks (too long)\n\nüí° **KEY:** **Smear negative + CXR suggestive ‚Üí CBNAAT** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    year: 2023
  },{
    id: "neet-pg-2023-192",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "r Which of the following is the sensitive indicator to assess the availability, utilization, and e effectiveness of healthcare in a community?",
    options: [
      "Infant mortality rate",
      "Maternal mortality rat d",
      "Immunization coverage",
      "Disability-adjusted life years",
    ],
    correctAnswer: 0,
    explanation: "‚úÖ ANSWER: **Infant mortality rate (IMR) (Option A)**\n\nüî¨ **INFANT MORTALITY RATE (IMR):**\n\n**DEFINITION:** ‚≠ê‚≠ê‚≠ê\n‚Ä¢ **Deaths <1 year** per 1000 live births\n‚Ä¢ IMR = (Deaths <1 year / Total live births) √ó 1000\n\n**MOST SENSITIVE INDICATOR** of health system ‚≠ê‚≠ê‚≠ê **(ANSWER)**\n\n**WHY IMR IS BEST:**\n‚Ä¢ **Reflects AVAILABILITY** of healthcare ‚≠ê\n‚Ä¢ **Reflects UTILIZATION** of services ‚≠ê\n‚Ä¢ **Reflects EFFECTIVENESS** of interventions ‚≠ê\n‚Ä¢ **Reflects** socio-economic status, nutrition, sanitation\n‚Ä¢ **Early indicator** of health system performance\n\n**COMPONENTS:**\n‚Ä¢ **Neonatal** (0-28 days) - 60-70% of IMR\n‚Ä¢ **Post-neonatal** (28 days - 1 year)\n\n**INDIA IMR:** ~28/1000 (2020)\n\n**WHY NOT OTHERS:**\n‚Ä¢ **MMR:** Important but **less sensitive** (fewer deaths)\n‚Ä¢ **Immunization coverage:** Reflects only ONE aspect\n‚Ä¢ **DALY:** Composite measure (disability + death)\n\n**OTHER HEALTH INDICATORS:**\n‚Ä¢ **MMR:** Maternal health\n‚Ä¢ **U5MR:** <5 years mortality\n‚Ä¢ **Life expectancy:** Overall health\n\nüí° **KEY:** **IMR = Most sensitive indicator of healthcare availability, utilization & effectiveness** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    imageUrl: "/images/questions/2023/page95_img49.jpeg",
    year: 2023
  },{
    id: "neet-pg-2023-200",
    subjectId: "preventive-medicine",
    chapterId: "neet-pg-2023",
    question: "The average daily dietary nutrienLt intake level sufficient to meet the nutrient requirements of nearly all (97-98%) healthy individuals in a particular life stage and gender group is known as?",
    options: [
      "Adequate intake p",
      "Dietary goal e",
      "Estimated average requirement",
      "Recommended dietary allowanc APns: 4 If you wish to access the detailed explanations for the correct an incorrect options of these questions, download the PrepLadder app now. Download PrepLadder's NEET PG app for Androi Download PrepLadder's NEET PG app for iOS",
    ],
    correctAnswer: 0,
    explanation: "‚úÖ ANSWER: **Recommended Dietary Allowance (RDA) - Likely Option D** \n\nüî¨ **DIETARY REFERENCE INTAKES (DRI):**\n\n**QUESTION:** Nutrient intake meeting needs of **97-98%** of healthy individuals ‚≠ê‚≠ê‚≠ê\n\n**ANSWER:** **RECOMMENDED DIETARY ALLOWANCE (RDA)** ‚≠ê‚≠ê‚≠ê\n\n**RDA DEFINITION:**\n‚Ä¢ **Meets needs of 97-98%** of population ‚≠ê‚≠ê‚≠ê **(ANSWER)**\n‚Ä¢ **2 SD above EAR** (EAR + 2SD)\n‚Ä¢ **Goal for individual intake**\n\n**OTHER DRI TERMS:**\n\n**EAR (Estimated Average Requirement):**\n‚Ä¢ **Meets needs of 50%** of population ‚≠ê\n‚Ä¢ **Median requirement**\n\n**AI (Adequate Intake):**\n‚Ä¢ **Used when RDA cannot be determined**\n‚Ä¢ **Observed/experimental** intake\n\n**UL (Tolerable Upper Intake Level):**\n‚Ä¢ **Maximum safe intake**\n‚Ä¢ **Above this:** Risk of adverse effects\n\n**DIETARY GOALS:**\n‚Ä¢ **Population-level** targets\n‚Ä¢ **Different from individual RDA**\n\n**HIERARCHY:**\nEAR (50%) < **RDA (97-98%)** < UL\n\nüí° **KEY:** **97-98% coverage = RDA (Recommended Dietary Allowance)** ‚≠ê‚≠ê‚≠ê",
    difficulty: "medium",
    imageUrl: "/images/questions/2023/page99_img53.jpeg",
    year: 2023
  }
];

export default questions;

// Helper function to get questions by chapter
export function getQuestionsByChapter(chapterId: string): Question[] {
  return questions.filter(q => q.chapterId === chapterId);
}

// Export question count
export const questionCount = questions.length;
